GGrantIndex
← Search

Phase II - Development of a Prophylactic Onchocerciasis Vaccine

$2,961,685N44FY2019AINIH

Pai Life Sciences, Inc., Seattle WA

Investigators

Abstract

To develop a vaccine for onchocerciasis to be used for disease control and elimination.

View original record on NIH RePORTER →